Post-myocardial Infarction Left Ventricular Dysfunction

• FDA approval · 2019-09-04
  FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)

  The FDA approved a supplemental application for VALSARTAN submitted by Macleods Pharmaceuticals Limited, indicating approval of changes to t…

• FDA approval · 2017-07-13
  FDA Approved: EPLERENONE — Original Application (Accord Healthcare, Inc.)

  FDA approved Accord Healthcare's original (ANDA) application for the generic drug eplerenone (Eplerenone). The product is intended for indic…

• FDA approval · 2015-10-02
  FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

  The FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC.

• FDA approval · 2015-08-25
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)

  The FDA approved a supplemental application for enalapril maleate submitted by Oceanside Pharmaceuticals, marking an approved labeling actio…

• FDA approval · 2013-05-07
  FDA Approved: CARVEDILOL — Supplemental Application (Sandoz Inc)

  The FDA approved a supplemental application for carvedilol submitted by Sandoz Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-09-05
  FDA Approved: CARVEDILOL — Original Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved Teva’s generic carvedilol under an Original Application (ANDA) for a generic version, expanding available generic options f…